(Q73410892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Captopril inhibits the production of tumor necrosis factor-alpha by human mononuclear cells in patients with congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

congestive heart failure

1 reference

S P Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

X M Xie

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

85-90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Cytokines and cardiac contractile function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Captopril and immune regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Captopril: a new treatment for rheumatoid arthritis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Tumour necrosis factor alpha in severe congestive cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

Effect of captopril or enalapril on renal prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900405-8

10.1016/S0009-8981(00)00405-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165202%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference